THERALINK TECHNOLOGIES, INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Theralink Technologies, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2011 to Q4 2023.
  • Theralink Technologies, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending December 31, 2023 was $45.8K, a 5.21% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $45.8K -$2.52K -5.21% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $23.9K -$8.22K -25.6% Sep 30, 2023 10-Q 2024-02-20
Q2 2023 $15K -$94.4K -86.3% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $40.6K -$96.4K -70.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $48.3K -$1.43K -2.88% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 $32.1K Sep 30, 2022 10-K 2024-01-05
Q2 2022 $109K -$40.6K -27.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $137K +$80.5K +142% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $49.7K Dec 31, 2021 10-Q 2022-02-18
Q2 2021 $150K +$125K +500% Jun 30, 2021 10-Q 2021-09-28
Q1 2021 $56.5K Mar 31, 2021 10-Q 2021-09-27
Q2 2020 $25K Jun 30, 2020 10-Q 2021-06-11
Q3 2019 $4K Sep 30, 2019 10-Q 2021-06-11
Q3 2017 $93.4K Sep 30, 2017 10-Q 2017-11-20
Q2 2017 $94.1K Jun 30, 2017 10-Q 2017-09-14
Q1 2017 $170K Mar 31, 2017 10-Q 2017-05-22
Q2 2013 $0 -$94.1K -100% May 31, 2013 10-Q 2013-07-31
Q1 2013 $50.6K -$56.1K -52.6% Feb 28, 2013 10-Q 2013-07-31
Q4 2012 $40.2K -$15.9K -28.3% Nov 30, 2012 10-Q 2013-01-22
Q3 2012 $65.7K +$35.1K +115% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 $94.1K May 31, 2012 10-Q 2012-07-13
Q1 2012 $107K +$51.6K +93.6% Feb 29, 2012 10-K 2013-06-28
Q4 2011 $56.1K Nov 30, 2011 10-Q 2012-01-17
Q3 2011 $30.6K Aug 31, 2011 10-Q 2011-10-17
Q1 2011 $55.1K Feb 28, 2011 10-K 2012-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.